$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review

The U.S. Supreme Court has declined to consider an appeal filed by Johnson & Johnson over a $70 million verdict for failing to warn about that side effects of Risperdal may cause male breast growth, meaning the judgment will stand.

In July 2016, a Philadelphia jury ordered Johnson & Johnson and its Janssen subsidiary to pay the family of Andrew Yount $70 million, after use of the atypical antipsychotic medication Risperdal as a five-year-old boy resulted in the development of a rare medical condition, known as gynecomastia.

Johnson & Johnson has faced thousands of Risperdal lawsuits brought by young men and families of minor boys who developed full breast growth after taking the medication, often resulting in devastating psychological consequences and the need for surgery to correct the problem.

Learn More About

Risperdal Lawsuits

Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia.


After a Philadelphia appeals court upheld the ruling, and the state’s highest court rejected an attempt to overturn the verdict, Johnson & Johnson petitioned the U.S. Supreme Court to consider the case.

In a docket entry posted on May 17, the Supreme Court denied the petition for review, noting that Justice Samuel Alito took no part in the consideration or decision on the petition.

At the time Yount was prescribed the drug, in 2003, it had not yet been approved for use in children, but was prescribed to him “off label.” The lawsuit alleged that there should have been a warning of the risk of gynecomastia, which did not appear on the drug until the FDA approved it for pediatric use in 2006. However, even before then, up to a third of all Risperdal prescriptions were “off label” for children.

Since the verdict in this case and other early bellwether trials, Johnson & Johnson has negotiated Risperdal settlements to resolve thousands of claims brought by individuals nationwide. However, a number of cases are still pending and expected to go before juries in the next few years.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted today)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted yesterday)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.